Literature DB >> 20594440

Predictive value of antimicrobial susceptibility from previous urinary tract infection in the treatment of re-infection.

Akke Vellinga1, Martin Cormican, Belinda Hanahoe, Andrew W Murphy.   

Abstract

Recurrent urinary tract infections are often re-infections; therefore, antimicrobial susceptibility test results from a previous episode may guide the empiric therapy in subsequent episodes. This analysis provides predictive values of the antimicrobial susceptibility of previous Escherichia coli isolates for the treatment of re-infections in routine clinical practice. If resistance to ampicillin, trimethoprim, or ciprofloxacin is detected, re-prescription within 3 months is imprudent. Susceptibility to nitrofurantoin, ciprofloxacin, or trimethoprim in a previous sample supports their prescription for a re-infection within 3 months and up to a year. Resistance to nitrofurantoin is low and, once detected, decays relatively quickly. Nitrofurantoin should be considered as a first-line agent for initial and repeat treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20594440      PMCID: PMC2894379          DOI: 10.3399/bjgp10X514765

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  7 in total

1.  From diagnostic accuracy to accurate diagnosis: interpreting a test result with confidence.

Authors:  Guangyong Zou
Journal:  Med Decis Making       Date:  2004 May-Jun       Impact factor: 2.583

2.  Risk factors for second urinary tract infection among college women.

Authors:  B Foxman; B Gillespie; J Koopman; L Zhang; K Palin; P Tallman; J V Marsh; S Spear; J D Sobel; M J Marty; C F Marrs
Journal:  Am J Epidemiol       Date:  2000-06-15       Impact factor: 4.897

3.  Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).

Authors:  J W Warren; E Abrutyn; J R Hebel; J R Johnson; A J Schaeffer; W E Stamm
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

Review 4.  Pathogenesis of urinary tract infections: an update.

Authors:  T M Hooton
Journal:  J Antimicrob Chemother       Date:  2000-09       Impact factor: 5.790

Review 5.  Recurrent urinary tract infection in women.

Authors:  T M Hooton
Journal:  Int J Antimicrob Agents       Date:  2001-04       Impact factor: 5.283

Review 6.  Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis.

Authors:  Mariska M G Leeflang; Patrick M M Bossuyt; Les Irwig
Journal:  J Clin Epidemiol       Date:  2008-09-07       Impact factor: 6.437

7.  WINPEPI (PEPI-for-Windows): computer programs for epidemiologists.

Authors:  Joseph H Abramson
Journal:  Epidemiol Perspect Innov       Date:  2004-12-17
  7 in total
  7 in total

1.  Managing UTI in primary care: should we be sending midstream urine samples?

Authors:  Alastair D Hay
Journal:  Br J Gen Pract       Date:  2010-07       Impact factor: 5.386

2.  Intervention to improve the quality of antimicrobial prescribing for urinary tract infection: a cluster randomized trial.

Authors:  Akke Vellinga; Sandra Galvin; Sinead Duane; Aoife Callan; Kathleen Bennett; Martin Cormican; Christine Domegan; Andrew W Murphy
Journal:  CMAJ       Date:  2015-11-16       Impact factor: 8.262

3.  Antibiotics for childhood urinary tract infection: can we be smarter?

Authors:  Alastair D Hay; Ceire Costelloe
Journal:  Br J Gen Pract       Date:  2013-04       Impact factor: 5.386

4.  Antimicrobial management and appropriateness of treatment of urinary tract infection in general practice in Ireland.

Authors:  Akke Vellinga; Martin Cormican; Belinda Hanahoe; Kathleen Bennett; Andrew W Murphy
Journal:  BMC Fam Pract       Date:  2011-10-03       Impact factor: 2.497

5.  Supporting the improvement and management of prescribing for urinary tract infections (SIMPle): protocol for a cluster randomized trial.

Authors:  Sinead Duane; Aoife Callan; Sandra Galvin; Andrew W Murphy; Christine Domegan; Eamon O'Shea; Martin Cormican; Kathleen Bennett; Martin O'Donnell; Akke Vellinga
Journal:  Trials       Date:  2013-12-23       Impact factor: 2.279

6.  A comparative analysis of prophylactic antimicrobial use in long-term care facilities in Ireland, 2013 and 2016.

Authors:  Meera Tandan; Rory O'Connor; Karen Burns; Helen Murphy; Sarah Hennessy; Fiona Roche; Sheila Donlon; Martin Cormican; Akke Vellinga
Journal:  Euro Surveill       Date:  2019-03

Review 7.  A guide for urogynecologic patient care utilizing telemedicine during the COVID-19 pandemic: review of existing evidence.

Authors:  Cara L Grimes; Ethan M Balk; Catrina C Crisp; Danielle D Antosh; Miles Murphy; Gabriela E Halder; Peter C Jeppson; Emily E Weber LeBrun; Sonali Raman; Shunaha Kim-Fine; Cheryl Iglesia; Alexis A Dieter; Ladin Yurteri-Kaplan; Gaelen Adam; Kate V Meriwether
Journal:  Int Urogynecol J       Date:  2020-04-27       Impact factor: 2.894

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.